Version history

{
  "session_id": "sess_SDA-2026-04-26-gap-debate-20260410-112902-5b3fc173",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "codex_task_runner",
  "action": "propose",
  "content": "Theorist assessment for gap gap-debate-20260410-112902-5b3fc173: Are age-related DNA methylation changes protective adaptations or pathological drivers in neurodegeneration?\n\nThe strongest causal model is that age-linked CpG drift interacts with cell-type composition shifts and then converges on protective chromatin remodeling. This is testable because the proposed drivers make temporally ordered predictions, not just cross-sectional associations. Three candidate hypotheses are:\n- age-linked CpG drift is the actionable driver in: Are age-related DNA methylation changes protective adaptations or pathological drivers in : The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, perturbing locus-specific epigenome editing should shift cell-sorted methylomes before downstream neurodegeneration markers change.\n- ATAC-seq accessibility separates causal from compensatory states in: Are age-related DNA methylation changes protective adaptations or pathological drive: A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective adaptation. The decisive experiment is to measure ATAC-seq accessibility before and after senescence stratification in stratified models.\n- protective chromatin remodeling defines the therapeutic window for: Are age-related DNA methylation changes protective adaptations or pathological dri: The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell methylome tracking should reveal a disease-stage interaction and define when intervention is protective versus counterproductive.\n\nKey predictions: cell-sorted methylomes should move before clinical decline; ATAC-seq accessibility should stratify responders; and locus-specific epigenome editing should reduce the downstream inflammatory or proteostatic signature in model systems.",
  "hypotheses_referenced": "[\"h-gap-e7852b55-m1\", \"h-gap-e7852b55-m2\", \"h-gap-e7852b55-m3\"]",
  "evidence_cited": "[]",
  "tokens_used": "485",
  "persona_id": "persona-theorist"
}